A presentation to: Meeting name Date

Slides:



Advertisements
Similar presentations
Glaucoma Clinical Update Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012.
Advertisements

ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
ESSAM OSMAN,FRCS ASSISTANT PROFESSOR,CONSULTANT DEPATMENT OF OPHTHALMOLOGY K.S.U.
0 Glaucoma can take your sight away. Keep Vision in Your Future.
Bitten by Ophthalmology Professor Helen Danesh-Meyer University of Auckland.
Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,
Glaucoma Region XI “The Hot Splinters”. Definition A group of diseases caused by damage to the optic nerve that can gradually eliminate all sight A group.
Better Health. No Hassles. A Healthy Eyes Healthy People Presentation Glaucoma… Knowing the Facts Can Save Your Sight.
Dr G. Chandrasekhar LVP Eye Health Pyramid Glaucoma Care.
Barrow, Brantley, Fredde, Gillispie
Will my Glaucoma patient lose vision ?
Adult Medical-Surgical Nursing Neurology Module: Glaucoma.
Anterior Segment Reconstruction in the Treatment of Chronic Angle Closure Glaucoma Anterior Segment Reconstruction in the Treatment of Chronic Angle Closure.
Dr. Abdullah Al-Amri Ophthalmology Consultant
Glaucoma By: Courtney, Madison, Justin.  A group of eye conditions that can cause blindness.  However, with early detection and treatment, you can.
GLAUCOMA.
Glaucoma.
Glaucoma Madhav Vempali Vempali Medical Ltd. Glaucoma The healthy eye Light rays enter the eye through the cornea, pupil and lens. These light rays are.
(Relates to Chapter 22, “Nursing Management: Visual and Auditory Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier.
Glaucoma “ The Sneak Thief of Sight." Julie DeMore Professor Don Williams NS215G.
Sensory.
Primary angle-closure glaucoma
The effects of Nd:YAG (neodymium: yttrium-aluminum-garnet) laser peripheral iridotomy (PI) on contra-lateral eye anterior chamber parameters of patients.
Glaucoma… Knowing the Facts Can Save Your Sight
Tulsi Changulani 1,*, Jenny Bo 2, Mei-Ling Cheng 1, Andrew Tatham 1
Safety of medication reduction for Primary Angle Closure (PAC) –
VISUAL ALTERATION GLAUCOMA.
Neuroretinal Rim Recovery In Narrow Angle Glaucoma After Intraocular Pressure Lowering With Topical Medications  – Case Report Božić M.1,2, Marković V.
Lasers in Glaucoma: Meta analysis
New concepts of Angle Closure Glaucoma
A presentation to: Meeting name Date
PRIMARY ANGLE-CLOSURE GLAUCOMA
A presentation to: Meeting name Date
From: The Effects of Study Design and Spectrum Bias on the Evaluation of Diagnostic Accuracy of Confocal Scanning Laser Ophthalmoscopy in Glaucoma Invest.
A presentation to: Meeting name Date
Glaucoma.
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Kyoto Prefectural University of Medicine
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Presentation transcript:

A presentation to: Meeting name Date Iridotomy to slow progression of visual field loss in angle-closure glaucoma Jimmy T Le, Benjamin Rouse, Gus Gazzard Issue 6, 2018 A presentation to: Meeting name Date

Table of Contents 01 Background 02 Types of studies 03 Key results 04 Tables (Risk of Bias/Forest Plots) 05 Conclusions 06 Acknowledgements

01: Background Primary angle-closure glaucoma is a type of glaucoma associated with a physically obstructed anterior chamber angle. Elevated IOP is associated with glaucomatous optic nerve damage and visual field loss. Laser peripheral iridotomy (often just called ‘iridotomy’) is a procedure to eliminate pupillary block by allowing aqueous humor to pass directly from the posterior to anterior chamber through use of a laser to create a hole in the iris. Objective To assess the effects of iridotomy compared with no iridotomy for primary angle-closure glaucoma, primary angle closure, and primary angle-closure suspects.

02: Types of studies Participants Two randomized controlled trials (RCTs) with 1251 participants (2502 eyes) with bilateral asymptomatic primary angle-closure suspects. Interventions Neodynium:yttrium-aluminium-garnet (Nd:YAG) laser iridotomy in one randomly selected eye. No iridotomy in the paired eye.

03: Key results “At the time of this review, no data are available on the proportion of participants with progressive visual field loss at one year… [or] on the mean change in IOP at one year… [or] on gonioscopic findings at one year” “Neither the ANA-LIS nor the ZAP trial specified measuring need for additional surgery… [or] measuring number of medications to control IOP… [or] measuring change in BCVA… [or] measuring quality of life”

04: Tables

05: Conclusions “The available studies that directly compared iridotomy to no iridotomy have not yet published full trial reports.” “At present, we cannot draw reliable conclusions based on randomized controlled trials as to whether iridotomy slows progression of visual field loss at one year compared to no iridotomy.”

06: Acknowledgements Cochrane Eyes and Vision US Satellite, funded by the National Eye Institute, National Institutes of Health Cochrane Eyes and Vision Editorial Base, funded by the UK National Health Service Research and Development Programme Jimmy T Le, Benjamin Rouse, Gus Gazzard Review citation Le JT, Rouse B, Gazzard G. Iridotomy to slow progression of visual field loss in angle‐closure glaucoma. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No.: CD012270. DOI: 10.1002/14651858.CD012270.pub2.